Coherus Oncology Inc. logo

Coherus Oncology Inc.

CHRS | NASDAQ
Chart Builder DCF Calculator
$1.33
-$0.04 (-2.92%)
Sep 22, 2026, 11:25 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
88.88M 125.99M 102.89M 63.55M 417.2M 541.16M
Short-Term Investments
83.25M n/a 14.86M 128.13M n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
4.05M 50.47M 77.18M 84.93M 65.64M 60.5M
Receivables
18.42M 122.33M 260.52M 109.96M 123.02M 157.05M
Inventory
3.17M 70.09M 62.61M 38.79M 37.64M 44.23M
Other Current Assets
6.23M 11.53M 11.1M 22.92M 10.8M n/a
Total Current Assets
206.71M 341.58M 475.63M 381.23M 602.32M 767.48M
Property-Plant & Equipment
1.35M 2.84M 5.12M 8.75M 7.81M 10.11M
Goodwill & Intangibles
46.24M 53.65M 71.67M 5.93M 3.56M 3.56M
Total Long-Term Assets
51.64M 106.95M 153.97M 99.61M 77.01M 74.17M
Total Assets
258.34M 448.53M 629.6M 480.85M 679.33M 841.65M
Account Payables
9.92M 28.46M 35.22M 11.53M 16.16M 15.2M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a
Other Current Liabilities
16.07M 33.11M 21.52M 22.61M 22.01M 22.24M
Total Current Liabilities
141.88M 282.98M 331.77M 138.69M 165.33M 145.65M
Long-Term Debt
37.05M 264.93M 473.37M 471.06M 408.28M 404.02M
Other Long-Term Liabilities
15.84M 28.23M 11.46M 3.47M 750K 1.05M
Total Long-Term Liabilities
55.45M 297.54M 491.26M 479.57M 416.28M 415.02M
Total Liabilities
197.33M 580.52M 823.03M 618.27M 581.61M 560.68M
Total Debt
40.34M 269.9M 480.84M 480.42M 419.02M 417.1M
Book Value
61.01M -131.99M -193.43M -137.42M 97.73M 280.97M
Book Value Per Share
0.51 -1.15 -2.05 -1.77 1.30 3.37
Common Stock
12K 12K 11K 8K 7K 7K
Retained Earnings
-1.38B -1.55B -1.58B -1.34B -1.05B -762.75M
Comprehensive Income
-195K -275K -248K -249K -270K -270K
Shareholders Equity
61.01M -131.99M -193.43M -137.42M 97.73M 280.97M
Total Investments
83.25M n/a 14.86M 128.13M n/a n/a

© 2026 bestshares.com. All rights reserved.